Nuvalent (NUVL) Short Interest Ratio & Short Volume $77.76 -0.59 (-0.75%) Closing price 04:00 PM EasternExtended Trading$77.76 -0.01 (-0.01%) As of 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nuvalent Short Interest DataNuvalent (NUVL) has a short interest of 5.49 million shares, representing 12.35% of the float (the number of shares available for trading by the public). This marks a -1.08% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.5, indicating that it would take 10.5 days of the average trading volume of 546,271 shares to cover all short positions.Current Short Interest5,490,000 sharesPrevious Short Interest5,550,000 sharesChange Vs. Previous Month-1.08%Dollar Volume Sold Short$455.40 millionShort Interest Ratio10.5 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares71,809,000 sharesFloat Size44,460,000 sharesShort Percent of Float12.35%Today's Trading Volume376,547 sharesAverage Trading Volume546,271 sharesToday's Volume Vs. Average69% Short Selling Nuvalent? Sign up to receive the latest short interest report for Nuvalent and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNUVL Short Interest Over TimeNUVL Days to Cover Over TimeNUVL Percentage of Float Shorted Over Time Nuvalent Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20255,490,000 shares $455.40 million -1.1%12.4%10.5 $82.95 6/30/20255,550,000 shares $423.47 million +6.5%12.5%9.5 $76.30 6/15/20255,210,000 shares $407.63 million -7.5%11.7%9.1 $78.24 5/31/20255,630,000 shares $414.54 million -3.6%12.7%9.4 $73.63 5/15/20255,840,000 shares $414.64 million -3.6%13.1%9.8 $71.00 4/30/20256,060,000 shares $465.11 million -6.5%13.6%10.2 $76.75 4/15/20256,480,000 shares $458.65 million +10.4%14.6%11.6 $70.78 3/31/20255,870,000 shares $416.30 million +6.9%13.2%10.6 $70.92 3/15/20255,490,000 shares $422.78 million -1.1%12.4%10.7 $77.01 2/28/20255,550,000 shares $416.14 million +1.5%12.5%11.1 $74.98 Get the Latest News and Ratings for NUVL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvalent and its competitors with MarketBeat's FREE daily newsletter. 2/15/20255,470,000 shares $426.28 million -4.5%12.4%12.1 $77.93 1/31/20255,730,000 shares $491.69 million -4.7%13.4%12.6 $85.81 1/15/20256,010,000 shares $465.41 million +5.6%14.0%12.2 $77.44 12/31/20245,690,000 shares $445.41 million +16.6%13.2%12.9 $78.28 12/15/20244,880,000 shares $423.88 million -3.9%11.4%11.1 $86.86 11/30/20245,080,000 shares $491.13 million +3.7%12.3%9.9 $96.68 11/15/20244,900,000 shares $425.71 million -5.2%11.8%9.1 $86.88 10/31/20245,170,000 shares $457.49 million -0.6%12.7%10.2 $88.49 10/15/20245,200,000 shares $532.58 million -6.8%13.5%11.1 $102.42 9/30/20245,580,000 shares $570.83 million -13.0%14.4%11.7 $102.30 9/15/20246,410,000 shares $560.55 million -6.7%17.6%13.9 $87.45 8/31/20246,870,000 shares $584.84 million +0.6%20.5%20.3 $85.13 8/15/20246,830,000 shares $491.15 million -1.6%20.4%19 $71.91 7/31/20246,940,000 shares $554.78 million -7.1%20.8%18.6 $79.94 7/15/20247,470,000 shares $608.43 million +3.3%22.4%19.3 $81.45 6/30/20247,230,000 shares $548.47 million +1.1%21.6%16.1 $75.86 6/15/20247,150,000 shares $556.13 million +6.4%21.4%15.4 $77.78 5/31/20246,720,000 shares $440.97 million -0.7%20.2%13.6 $65.62 5/15/20246,770,000 shares $485.27 million +2.1%20.3%14.3 $71.68 4/30/20246,630,000 shares $456.67 million -3.2%20.1%13.7 $68.88 4/15/20246,850,000 shares $447.17 million +6.0%21.0%14.5 $65.28 3/31/20246,460,000 shares $485.08 million -8.4%20.2%15.5 $75.09 3/15/20247,050,000 shares $569.64 million +7.8%22.8%18.3 $80.80 2/29/20246,540,000 shares $550.14 million -0.2%21.1%15.1 $84.12 2/15/20246,550,000 shares $553.48 million +4.0%21.7%15 $84.50 1/31/20246,300,000 shares $473.57 million -2.2%20.1%14 $75.17 1/15/20246,440,000 shares $481.20 million +3.5%20.6%12.7 $74.72 12/31/20236,220,000 shares $457.73 million +4.0%19.7%9.8 $73.59 12/15/20235,980,000 shares $480.07 million -4.6%19.0%7.9 $80.28 11/30/20236,270,000 shares $409.87 million -4.7%20.0%8.7 $65.37Leaked Gov’t Memo Reveals $100 Trillion Deadline (Ad)Only Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.Click here now to discover the full story and how to stake your claim before this land rush goes ful 11/15/20236,580,000 shares $388.22 million No Change21.0%9.4 $59.00 10/31/20236,580,000 shares $342.75 million +11.5%23.1%9.8 $52.09 10/15/20235,900,000 shares $342.14 million +9.3%20.8%9.2 $57.99 9/30/20235,400,000 shares $248.24 million +12.7%22.0%10.6 $45.97 9/15/20234,790,000 shares $226.85 million +7.2%19.5%14.2 $47.36 8/31/20234,470,000 shares $203.70 million -2.4%10.0%14.8 $45.57 8/15/20234,580,000 shares $193.14 million +2.0%10.3%15.1 $42.17 7/31/20234,490,000 shares $223.83 million -2.0%10.1%15.2 $49.85 7/15/20234,580,000 shares $189.80 million No Change10.3%15.7 $41.44 6/30/20234,580,000 shares $193.14 million No Change10.3%15.6 $42.17 6/15/20234,580,000 shares $204.63 million +17.7%10.3%15.5 $44.68 5/31/20233,890,000 shares $163.77 million +5.7%8.8%13.7 $42.10 5/15/20233,680,000 shares $149.92 million +5.8%8.3%13.9 $40.74 4/30/20233,480,000 shares $123.16 million -8.4%7.9%13.3 $35.39 4/15/20233,800,000 shares $107.69 million -6.2%8.6%15.9 $28.34 3/31/20234,050,000 shares $105.66 million +9.8%9.2%17.8 $26.09 3/15/20233,690,000 shares $103.65 million +13.2%8.4%18.7 $28.09 2/28/20233,260,000 shares $98.75 million +3.8%7.4%16.2 $30.29 2/15/20233,140,000 shares $95.05 million -0.3%7.2%14.8 $30.27 1/31/20233,150,000 shares $95.29 million +19.3%7.2%13.7 $30.25 1/15/20232,640,000 shares $85.62 million +3.5%6.0%6.9 $32.43 12/30/20222,550,000 shares $75.94 million +8.1%5.8%6.8 $29.78 12/15/20222,360,000 shares $70.16 million -2.5%5.4%6.3 $29.73 11/30/20222,420,000 shares $79.57 million -5.1%5.7%6.9 $32.88 11/15/20222,550,000 shares $83.16 million -23.2%6.0%7.5 $32.61 10/31/20223,320,000 shares $118.56 million -0.9%9.2%10.9 $35.71 10/15/20223,350,000 shares $69.45 million -9.2%9.3%25.1 $20.73 9/30/20223,690,000 shares $71.73 million +8.5%10.2%26.7 $19.44 9/15/20223,400,000 shares $61.03 million -3.7%9.4%22 $17.95 8/31/20223,530,000 shares $59.59 million -3.6%9.9%21.2 $16.88 8/15/20223,660,000 shares $62.18 million -3.4%10.2%21.4 $16.99 7/31/20223,790,000 shares $56.32 million -2.8%10.9%20.4 $14.86 7/15/20223,900,000 shares $65.09 million -18.8%11.2%22 $16.69 6/30/20224,800,000 shares $65.09 million +1.9%13.7%28.3 $13.56 6/15/20224,710,000 shares $45.40 million +9.8%13.5%30.4 $9.64 5/31/20224,290,000 shares $38.01 million +8.1%12.3%24.7 $8.86 5/15/20223,970,000 shares $31.76 million -2.5%11.4%22 $8.00 4/30/20224,070,000 shares $41.88 million +0.7%11.7%22.4 $10.29 4/15/20224,040,000 shares $48.04 million +5.5%11.6%21.6 $11.89 3/31/20223,830,000 shares $53.20 million +3.8%11.0%19.1 $13.89 3/15/20223,690,000 shares $45.94 million +15.3%10.6%19 $12.45 2/28/20223,200,000 shares $47.84 million +3.9%9.2%20.8 $14.95 2/15/20223,080,000 shares $56.43 million +15.4%8.8%22.7 $18.32 1/31/20222,670,000 shares $36.02 million +24.8%7.6%24.4 $13.49 1/15/20222,140,000 shares $27.18 million +18.9%5.9%23 $12.70 12/31/20211,800,000 shares $34.27 million -3.2%5.0%22.1 $19.04 12/15/20211,860,000 shares $40.42 million +21.6%5.1%22.5 $21.73 11/30/20211,530,000 shares $32.63 million +7.0%4.2%11.8 $21.33 11/15/20211,430,000 shares $34.41 million +1.4%4.0%9.4 $24.06 10/29/20211,410,000 shares $34.45 million -17.5%3.8%8.6 $24.43Leaked Gov’t Memo Reveals $100 Trillion Deadline (Ad)Only Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.Click here now to discover the full story and how to stake your claim before this land rush goes ful 10/15/20211,710,000 shares $34.08 million +18.8%4.6%7.9 $19.93 9/30/20211,440,000 shares $32.47 million +48.8%3.9%5.7 $22.55 9/15/2021967,700 shares $36.77 million +27.7%2.6%3.3 $38.00 8/31/2021757,900 shares $27.61 million +104.0%2.1%3 $36.43 8/13/2021371,600 shares $8.32 million No Change1.0%1.5 $22.38 NUVL Short Interest - Frequently Asked Questions What is Nuvalent's current short interest? Short interest is the volume of Nuvalent shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 5,490,000 shares of NUVL short. 12.35% of Nuvalent's shares are currently sold short. Learn More on Nuvalent's current short interest. What is a good short interest ratio for Nuvalent? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NUVL shares currently have a short interest ratio of 10.0. Learn More on Nuvalent's short interest ratio. Which institutional investors are shorting Nuvalent? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Nuvalent: Twin Tree Management LP, Jane Street Group LLC, Caption Management LLC, Twin Tree Management LP, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Nuvalent? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.35% of Nuvalent's floating shares are currently sold short. Is Nuvalent's short interest increasing or decreasing? Nuvalent saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 5,490,000 shares, a drop of 1.1% from the previous total of 5,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Nuvalent's float size? Nuvalent currently has issued a total of 71,809,000 shares. Some of Nuvalent's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nuvalent currently has a public float of 44,460,000 shares. How does Nuvalent's short interest compare to its competitors? 12.35% of Nuvalent's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nuvalent: Summit Therapeutics PLC (3.85%), Insmed, Inc. (5.11%), Teva Pharmaceutical Industries Ltd. (4.66%), Genmab A/S Sponsored ADR (0.60%), Moderna, Inc. (19.34%), Dr. Reddy's Laboratories Ltd (1.46%), QIAGEN N.V. (2.93%), Viatris Inc. (3.32%), Ascendis Pharma A/S (4.46%), Verona Pharma PLC American Depositary Share (5.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Nuvalent stock? Short selling NUVL is an investing strategy that aims to generate trading profit from Nuvalent as its price is falling. NUVL shares are trading down $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nuvalent? A short squeeze for Nuvalent occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NUVL, which in turn drives the price of the stock up even further. How often is Nuvalent's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NUVL, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies SMMT Short Interest INSM Short Interest TEVA Short Interest GMAB Short Interest MRNA Short Interest RDY Short Interest QGEN Short Interest VTRS Short Interest ASND Short Interest VRNA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NUVL) was last updated on 8/1/2025 by MarketBeat.com Staff From Our PartnersWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!99.8% voted YES on this crypto partnership Kraken—one of the world's biggest crypto exchanges—just picked O...Crypto 101 Media | SponsoredThe Dollar’s Crashing—What Are You Doing About It?The U.S. dollar is down 10.8%—its steepest drop since 1973. As global confidence in the dollar fades, centr...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUVL Stock Alerts